Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisH

Domperidone for lactating women

Orlando P. da Silva and David C. Knoppert
CMAJ September 28, 2004 171 (7) 725-726; DOI: https://doi.org/10.1503/cmaj.1041054
Orlando P. da Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Knoppert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Have they studied it properly ?
    Dr. A. LakKumar Fernando
    Posted on: 29 September 2004
  • Posted on: (29 September 2004)
    Page navigation anchor for Have they studied it properly ?
    Have they studied it properly ?
    • Dr. A. LakKumar Fernando, Consultant Paediatrician, General Hospital, Chilaw, Sri Lanka

    Recommendations on domperidone in lactating women is based on the effects of IV high dose.

    As a Consultant Paediatrician I have asked(prescribed)well over 1000 women to take Domperidone at a dose of 10mg t.i.d for 14 days in order to help breast feeding(to increase supply of breast milk) and think it works well for many. I have never come across a single women developing any symptoms suggestive of arrhythmias w...

    Show More

    Recommendations on domperidone in lactating women is based on the effects of IV high dose.

    As a Consultant Paediatrician I have asked(prescribed)well over 1000 women to take Domperidone at a dose of 10mg t.i.d for 14 days in order to help breast feeding(to increase supply of breast milk) and think it works well for many. I have never come across a single women developing any symptoms suggestive of arrhythmias with this dose. I know of many colleagues of mine who do the same and they too have a similar experience. In Sri Lanka over 95% of babies will be breast fed within the 1st month and about 70% will continue to breast feed even at 6 months. For a few who have initial problems domperidone help and should we deprive those women and their babies of such benifits? It is well known that paracetamol is fatally toxic at high doses even when taken orally but that does not prevent thousands taking it at the proper dose for pain or fever. I recently learnt that FDA approves the use of Polycarbonate Plastic Bottles to feed infants though there are concerns about its safety. There FDA appears to 'assume safty and ask to prove harm by plastic bottles' but act differently when it comes to breast feeding.

    Dr. A LakKumar Fernando MBBS(SL),DCH,MD(Paed),MRCP(UK),MRCPCH(UK) Consultant Paediatrician, General Hospital, Chilaw, Sri Lanka.

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 171 (7)
CMAJ
Vol. 171, Issue 7
28 Sep 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Domperidone for lactating women
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Domperidone for lactating women
Orlando P. da Silva, David C. Knoppert
CMAJ Sep 2004, 171 (7) 725-726; DOI: 10.1503/cmaj.1041054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Domperidone for lactating women
Orlando P. da Silva, David C. Knoppert
CMAJ Sep 2004, 171 (7) 725-726; DOI: 10.1503/cmaj.1041054
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • PubMed
  • Google Scholar

Cited By...

  • Effect of Domperidone on the Composition of Preterm Human Breast Milk
  • Growth and Nutrient Intakes of Human Milk-Fed Preterm Infants Provided With Extra Energy and Nutrients After Hospital Discharge
  • Google Scholar

More in this TOC Section

  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Breastfeeding & infant nutrition
    • Drugs: adverse reactions

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire